GlassScriptPhysician profile
Kyle R Varvel
NPI 1730316076
$7,749.40
in general payments reported to CMS, 2019-2025
27 companies · $1,725 in 2025
The $1,725 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $783 · 2021: $1,080 · 2022: $1,440 · 2023: $1,345 · 2024: $644 · 2025: $1,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,685 · Honoraria: $25.59 · Education: $2.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,684.62 |
| Honoraria | $25.59 |
| Education | $2.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,442.28 | 2019-2025 | Istent Inject Trabecular Micro-Bypass System, Kxl System (Not Refurbished), Idosetr |
| Alcon Vision LLC | $1,370.89 | 2019-2025 | Clareon, Lensx, Tryptyr |
| Bausch & Lomb Americas INC. | $788.94 | 2022-2025 | Envista Mx60 Iol, Miebo, Envista Envy Iol |
| Biotissue Holdings INC. | $766.61 | 2025 | |
| Ocular Therapeutix, INC. | $540.28 | 2020-2025 | Dextenza |
| Rxsight INC | $470.28 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Sun Pharmaceutical Industries INC. | $424.89 | 2019-2025 | Cequa |
| Abbvie INC. | $240.50 | 2022-2025 | Lumigan, Vuity, Alphagan P |
| Lensar, INC. | $215.89 | 2025 | Lensar Laser System |
| Novartis Pharmaceuticals Corporation | $192.93 | 2019-2023 | |
| Shire North American Group INC | $185.78 | 2019 | |
| Kala Pharmaceuticals, INC. | $145.62 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.84 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $114.33 | 2020-2021 | |
| Dompe US, INC. | $111.18 | 2024-2025 | Oxervate |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $98.34 | 2022-2023 | Tyrvaya |
| Sight Sciences, INC. | $90.53 | 2022-2023 | Omni Surgical System |
| Allergan, INC. | $71.88 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $69.33 | 2021 | |
| Horizon Therapeutics Plc | $67.98 | 2021-2023 | Tepezza |
| Harrow Eye, LLC | $66.58 | 2025 | Triesence, Vevye |
| Carl Zeiss Meditec, INC. | $39.07 | 2020 | |
| Rayner Intraocular Lenses Limited | $31.43 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $27.02 | 2019 | |
| Amgen INC. | $19.58 | 2025 | Tepezza |
| Omeros Corporation | $18.98 | 2019 | |
| New World Medical,INC. | $18.44 | 2025 | Kahook Dual Blade, Via360, Streamline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Varvel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.